2015-004905-17
Study to evaluate the efficacy and safety of Paxil® Tablets in children and adolescents with Major Depressive Disorder
GlaxoSmithKline Research & Development·EU Clinical Trials Register
Study focus
- Disease/Condition
- Major Depressive Disorder
Sponsor & location
- Primary sponsor
- GlaxoSmithKline Research & Development
- Funder
- GlaxoSmithKline
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
Change from baseline in the CDRS-R total score at Week 8 [Time Frame: Baseline and Week 8]
ICD-10 classifications
Recurrent depressive disorderRecurrent depressive disorder, unspecifiedDepressive conduct disorderOther recurrent depressive disordersRecurrent depressive disorder, current episode moderate
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2015-004905-17
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2015-004905-17 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline Research & Development and is currently status unknown. The study focuses on Major Depressive Disorder.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.